BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 19234610)

  • 1. Probing evolutionary repeatability: neutral and double changes and the predictability of evolutionary adaptation.
    Roy SW
    PLoS One; 2009; 4(2):e4500. PubMed ID: 19234610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Network models of TEM β-lactamase mutations coevolving under antibiotic selection show modular structure and anticipate evolutionary trajectories.
    Guthrie VB; Allen J; Camps M; Karchin R
    PLoS Comput Biol; 2011 Sep; 7(9):e1002184. PubMed ID: 21966264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Fitness of Beta-Lactamase Mutants Depends Nonlinearly on Resistance Level at Sublethal Antibiotic Concentrations.
    Farr AD; Pesce D; Das SG; Zwart MP; de Visser JAGM
    mBio; 2023 Jun; 14(3):e0009823. PubMed ID: 37129484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutation supply and the repeatability of selection for antibiotic resistance.
    van Dijk T; Hwang S; Krug J; de Visser JAGM; Zwart MP
    Phys Biol; 2017 Aug; 14(5):055005. PubMed ID: 28699625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Environmental changes bridge evolutionary valleys.
    Steinberg B; Ostermeier M
    Sci Adv; 2016 Jan; 2(1):e1500921. PubMed ID: 26844293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Initial mutations direct alternative pathways of protein evolution.
    Salverda ML; Dellus E; Gorter FA; Debets AJ; van der Oost J; Hoekstra RF; Tawfik DS; de Visser JA
    PLoS Genet; 2011 Mar; 7(3):e1001321. PubMed ID: 21408208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enzyme Efficiency but Not Thermostability Drives Cefotaxime Resistance Evolution in TEM-1 β-Lactamase.
    Knies JL; Cai F; Weinreich DM
    Mol Biol Evol; 2017 May; 34(5):1040-1054. PubMed ID: 28087769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Darwinian evolution can follow only very few mutational paths to fitter proteins.
    Weinreich DM; Delaney NF; Depristo MA; Hartl DL
    Science; 2006 Apr; 312(5770):111-4. PubMed ID: 16601193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adaptive benefits from small mutation supplies in an antibiotic resistance enzyme.
    Salverda MLM; Koomen J; Koopmanschap B; Zwart MP; de Visser JAGM
    Proc Natl Acad Sci U S A; 2017 Nov; 114(48):12773-12778. PubMed ID: 29133391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evolutionary accessibility of mutational pathways.
    Franke J; Klözer A; de Visser JA; Krug J
    PLoS Comput Biol; 2011 Aug; 7(8):e1002134. PubMed ID: 21876664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SHV-129: A Gateway to Global Suppressors in the SHV β-Lactamase Family?
    Winkler ML; Bonomo RA
    Mol Biol Evol; 2016 Feb; 33(2):429-41. PubMed ID: 26531195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mistranslation can promote the exploration of alternative evolutionary trajectories in enzyme evolution.
    Zheng J; Bratulic S; Lischer HEL; Wagner A
    J Evol Biol; 2021 Aug; 34(8):1302-1315. PubMed ID: 34145657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bypass of genetic constraints during mutator evolution to antibiotic resistance.
    Couce A; Rodríguez-Rojas A; Blázquez J
    Proc Biol Sci; 2015 Apr; 282(1804):20142698. PubMed ID: 25716795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Temporal constraints on the incorporation of regulatory mutants in evolutionary pathways.
    Brown KM; Depristo MA; Weinreich DM; Hartl DL
    Mol Biol Evol; 2009 Nov; 26(11):2455-62. PubMed ID: 19602543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Empirical fitness landscapes and the predictability of evolution.
    de Visser JA; Krug J
    Nat Rev Genet; 2014 Jul; 15(7):480-90. PubMed ID: 24913663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting the emergence of antibiotic resistance by directed evolution and structural analysis.
    Orencia MC; Yoon JS; Ness JE; Stemmer WP; Stevens RC
    Nat Struct Biol; 2001 Mar; 8(3):238-42. PubMed ID: 11224569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantifying the Determinants of Evolutionary Dynamics Leading to Drug Resistance.
    Chevereau G; Dravecká M; Batur T; Guvenek A; Ayhan DH; Toprak E; Bollenbach T
    PLoS Biol; 2015; 13(11):e1002299. PubMed ID: 26581035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mistranslation can enhance fitness through purging of deleterious mutations.
    Bratulic S; Toll-Riera M; Wagner A
    Nat Commun; 2017 May; 8():15410. PubMed ID: 28524864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolutionary potential of an RNA virus.
    Makeyev EV; Bamford DH
    J Virol; 2004 Feb; 78(4):2114-20. PubMed ID: 14747576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Shifting Fitness and Epistatic Landscapes Reflect Trade-offs along an Evolutionary Pathway.
    Steinberg B; Ostermeier M
    J Mol Biol; 2016 Jul; 428(13):2730-43. PubMed ID: 27173379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.